AI-generated from publicly available materials.The Advanced Research Projects Agency for Health (ARPA-H) has launched the ADVOCATE program, allocating up to $33.7 million in its first year to enhance cardiovascular care through AI technology. This initiative aims to bridge the significant geographic gaps in cardiac care across the U.S.
The ADVOCATE program will see collaboration among several organizations, including Atman Health, Tempus AI, and UpDoc, who will focus on developing AI-driven clinical tools and patient engagement systems. Stanford University will contribute by creating a supervisory AI agent to monitor these systems for patient safety. Implementation and validation will be carried out by Duke University and Kaiser Permanente, while the Johns Hopkins University Applied Physics Laboratory will evaluate the program's technical performance and clinical outcomes.
Cardiovascular disease remains a leading cause of death in the U.S., with over 200,000 deaths annually attributed to preventable factors. The ADVOCATE initiative aims to save lives by reducing hospitalizations and potentially generating significant cost savings—estimated at $28 billion per year. The program's goal is to develop an autonomous AI agent capable of understanding patient needs and autonomously providing care when appropriate, while also engaging human clinicians when necessary.
This ambitious project represents a critical step toward integrating AI into healthcare, particularly in underserved regions, where access to cardiology services is limited. As ARPA-H collaborates with the FDA to establish a regulatory framework for these innovations, the success of ADVOCATE could set a precedent for future AI applications in healthcare, ultimately leading to improved patient outcomes and more equitable access to care.